Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Canadian researchers working with Toronto General Hospital-University Health Network have developed a natural language processing (NLP) approach to predicting downstream radiology resource utilization, according to work published in the Journal of the American College of Radiology March 2.
The FDA on March 7 granted Breakthrough Device designation to Paige.AI, a year-old New York startup that’s using AI to help diagnose and treat cancer, the company announced.
The rapid advancement of AI technologies has left the medical community in a state of flux, unsure of where to direct their efforts to deliver the best, most effective care. But to one dean the answer is simple: prioritize patients.
A collaboration between Boston-based pharmaceutical startup Berg and French company Sanofi could one day result in more precise flu vaccines and even personalized shots tailored to individuals’ unique immune systems, Time reported March 5.
Though the idea of artificial intelligence displacing radiologists worries more than half of surveyed medical students interested in an imaging career, radiology programs have seen a spike in applications in recent years, according to work published in Academic Radiology.
AI systems can detect breast cancer just as well as radiologists, according to a study published March 5 in the Journal of the National Cancer Institute.
